Stabilisiertes Sulforaphan

European patent · EP2796140 · In force

Register entry

Publication number
EP2796140
Application number
EP14166888
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 23, 2008
Published
Oct 29, 2014
Granted
May 2, 2018
Protection ends at the latest
Jan 22, 2028
Next annual fee due
Jan 31, 2027
IPC classes
A61K 31/70 (2006.01)
A61K 31/40 (2006.01)
A61K 8/00 (2006.01)
A61K 31/26 (2006.01)
A61K 47/40 (2006.01)
B82Y 5/00 (2011.01)
Priority
US 881875 P 23.01.2007
Divided from
EP08724719
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 11, 2026

    Change

    Published in Swissreg on 11.02.2026

  2. Feb 19, 2025

    Change

    Published in Swissreg on 19.02.2025

  3. Feb 5, 2024

    Change

    Published in Swissreg on 05.02.2024

  4. Feb 2, 2023

    Change

    Published in Swissreg on 02.02.2023

  5. Jun 20, 2018

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 20.06.2018

  6. May 2, 2018

    Granted

    Published in Swissreg on 02.05.2018

Parties

Holder

PharmAgra Labs, Inc.

Pharmagra Labs, Inc.

40 McLean Road, Brevard, NC 28801, US

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

Frisbee, Albert, Roger

Hendersonville, NC North Carolina 28792, US

Newsome, Peter, Wyatt

Horse Shoe, NC North Carolina 28742, US

Baudet, Michel, Pierre

Durham, NC North Carolina 27704, US

Dagan, Ido, Dov

Raleigh, NC North Carolina 27603, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.